These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 2184899
1. Effects of dexamethasone on the availability of L-tryptophan and on the insulin and FFA concentrations in unipolar depressed patients. Maes M, Jacobs MP, Suy E, Vandewoude M, Minner B, Raus J. Biol Psychiatry; 1990 Apr 15; 27(8):854-62. PubMed ID: 2184899 [Abstract] [Full Text] [Related]
2. The relationships between the cortisol responses to dexamethasone and to L-5-HTP, and the availability of L-tryptophan in depressed females. Maes M, Vandewoude M, Schotte C, Maes L, Martin M, Scharpe S, Blockx P. Biol Psychiatry; 1990 Mar 15; 27(6):601-8. PubMed ID: 2322619 [Abstract] [Full Text] [Related]
3. The decreased availability of L-tryptophan in depressed females: clinical and biological correlates. Maes M, Vandewoude M, Schotte C, Martin M, D'Hondt P, Scharpe S, Blockx P. Prog Neuropsychopharmacol Biol Psychiatry; 1990 Mar 15; 14(6):903-19. PubMed ID: 2177560 [Abstract] [Full Text] [Related]
4. The diagnostic performance of the L-tryptophan/competing amino acids ratio in major depression. Maes M, De Ruyter M, Hobin P, Suy E. Acta Psychiatr Belg; 1986 Mar 15; 86(3):257-65. PubMed ID: 3751649 [Abstract] [Full Text] [Related]
5. Disturbances in dexamethasone suppression test and lower availability of L-tryptophan and tyrosine in early puerperium and in women under contraceptive therapy. Maes M, Claes M, Schotte C, Delbeke L, Jacquemyn Y, Verkerk R, De Meester I, Scharpé S. J Psychosom Res; 1992 Feb 15; 36(2):191-7. PubMed ID: 1560430 [Abstract] [Full Text] [Related]
6. Relationship between the dexamethasone suppression test and the L-tryptophan/competing amino acids ratio in depression. Maes M, De Ruyter M, Hobin P, Suy E. Psychiatry Res; 1987 Aug 15; 21(4):323-35. PubMed ID: 3628615 [Abstract] [Full Text] [Related]
7. Serum postdexamethasone prolactin measures in depressive patients and control subjects. Maes M, Schotte C, Peeters D, D'Hondt P, Martin M, Blockx P, Minner B, Suy E, Cosyns P. J Psychiatr Res; 1991 Aug 15; 25(3):109-16. PubMed ID: 1941707 [Abstract] [Full Text] [Related]
8. The effects of glucocorticoids on the availability of L-tryptophan and tyrosine in the plasma of depressed patients. Maes M, Schotte C, Scharpé S, Martin M, Blockx P. J Affect Disord; 1990 Feb 15; 18(2):121-7. PubMed ID: 2137469 [Abstract] [Full Text] [Related]
9. Plasma L-tryptophan/neutral amino acid ratio and dexamethasone suppression in depression. Joseph MS, Brewerton TD, Reus VI, Stebbins GT. Psychiatry Res; 1984 Mar 15; 11(3):185-92. PubMed ID: 6587412 [Abstract] [Full Text] [Related]
10. Suppressant effects of dexamethasone on the availability of plasma L-tryptophan and tyrosine in healthy controls and in depressed patients. Maes M, Jacobs MP, Suy E, Minner B, Leclercq C, Christiaens F, Raus J. Acta Psychiatr Scand; 1990 Jan 15; 81(1):19-23. PubMed ID: 2330824 [Abstract] [Full Text] [Related]
11. Biological heterogeneity of melancholia: results of pattern recognition methods. Maes M, Schotte C, D'Hondt P, Claes M, Vandewoude M, Scharpe S, Cosyns P. J Psychiatr Res; 1991 Jan 15; 25(3):95-108. PubMed ID: 1658316 [Abstract] [Full Text] [Related]
12. Prediction of subtype and severity of depression by means of dexamethasone suppression test, L-tryptophan: competing amino acid ratio, and MHPG flow. Maes MH, De Ruyter M, Suy E. Biol Psychiatry; 1987 Feb 15; 22(2):177-88. PubMed ID: 3814668 [Abstract] [Full Text] [Related]
13. The clinical use of the dexamethasone suppression test in DSM-III affective disorders: correlation with the severe depressive subtypes of melancholia and psychosis. Evans DL, Nemeroff CB. J Psychiatr Res; 1987 Feb 15; 21(2):185-94. PubMed ID: 3585807 [Abstract] [Full Text] [Related]
14. Clinical subtypes of unipolar depression: Part III. Quantitative differences in various biological markers between the cluster-analytically generated nonvital and vital depression classes. Maes M, Maes L, Schotte C, Vandewoude M, Martin M, D'Hondt P, Blockx P, Scharpé S, Cosyns P. Psychiatry Res; 1990 Oct 15; 34(1):59-75. PubMed ID: 2176296 [Abstract] [Full Text] [Related]
15. The dexamethasone suppression test, the Hamilton Depression Rating Scale and the DSM-III depression categories. Maes M, De Ruyter M, Hobin P, Suy E. J Affect Disord; 1986 Oct 15; 10(3):207-14. PubMed ID: 2943774 [Abstract] [Full Text] [Related]
16. An augmented escape of beta-endorphins to suppression by dexamethasone in severely depressed patients. Maes M, Jacobs MP, Suy E, Leclercq C, Christiaens F, Raus J. J Affect Disord; 1990 Mar 15; 18(3):149-56. PubMed ID: 2139059 [Abstract] [Full Text] [Related]
17. Increased plasma serine concentrations in depression. Maes M, De Backer G, Suy E, Minner B. Neuropsychobiology; 1995 Mar 15; 31(1):10-5. PubMed ID: 7708176 [Abstract] [Full Text] [Related]
18. Hypothalamic-pituitary-adrenal and -thyroid axis dysfunctions and decrements in the availability of L-tryptophan as biological markers of suicidal ideation in major depressed females. Maes M, Vandewoude M, Schotte C, Martin M, Blockx P, Scharpe S, Cosyns P. Acta Psychiatr Scand; 1989 Jul 15; 80(1):13-7. PubMed ID: 2548371 [Abstract] [Full Text] [Related]
19. Sex-related differences in the relationships between self-rated depression and biological markers. Maes M, De Ruyter M, Claes R, Suy E. J Affect Disord; 1988 Jul 15; 15(2):119-25. PubMed ID: 2975681 [Abstract] [Full Text] [Related]
20. Results of the 8 a.m. dexamethasone suppression test constitute a suitable tool for confirming the diagnosis of melancholia. A test unaffected by the variations in the bioavailability of dexamethasone. Maes M, Vandewoude M, Schotte C, Cosyns P. Neuropsychobiology; 1989 Jul 15; 22(1):26-32. PubMed ID: 2639285 [Abstract] [Full Text] [Related] Page: [Next] [New Search]